Responses
Scientific Abstracts
Poster Presentations
Posters
Rheumatoid arthritis – non-biologic treatment and small molecules
THU0153 Improvements in disease activity score by baseline status: Pooled analysis of five phase 3 studies with tofacitinib (CP-690,550) in patients with active rheumatoid arthritis
Compose a Response to This Article
Other responses
No responses have been published for this article.